MedTrace Logo

Cannabis Impairment Detection Device Study

NCT07122349 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 362

Last updated 2025-08-17

No results posted yet for this study

Summary

The goal of this study is to develop a cannabis impairment detection device in adult cannabis users. The main question\[s\] it aims to answer are:

* Is the investigational device accurate and reliable at detecting cannabis impairment?
* is the device safe for the collection of eye movement data from cannabis intoxicated individuals? Participants will be administered a series of Drug Recognition Expert Ocular Tests via the Gaize headset following cannabis consumption.

Conditions

  • Cannabis Intoxication

Interventions

DEVICE

Cannabis Impairment Test

Automated Drug Recognition Expert Ocular Tests administered via VR Headset, includes test for Lack of Smooth Pursuit, Horizontal and Vertical Gaze Nystagmus, Lack of Convergence, and Pupillary Rebound Dilation. Tests are preceded by an automated system calibration process.

Sponsors & Collaborators

  • Dicentra Inc.

    collaborator INDUSTRY

  • Gaize

    lead INDUSTRY

Principal Investigators

  • Ken Fichtler · Gaize

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-08
Primary Completion
2022-10-24
Completion
2022-10-24

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07122349 on ClinicalTrials.gov